NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
$22.21 -0.9 (-3.8944%)
Analysed NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) News Sources
A Look At NewAmsterdam Pharma (NAMS) Valuation As Hedge Funds Focus On Obicetrapib’s Phase 3 LDL C Results
09-04-2026
yahoo.com
NewAmsterdam Pharma Company (NAMS): Huge Upside Potential Grabs Attention of Billionaire Stan Druckenmiller
08-04-2026
yahoo.com
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
08-04-2026
yahoo.com
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-04-2026
yahoo.com
Here’s Why NewAmsterdam Pharma Company N.V. (NAMS) Surged 23% in Q4
02-04-2026
yahoo.com
Upcoming Obicetrapib Phase 3 Data at ACC.26 Might Change The Case For Investing In NewAmsterdam Pharma (NAMS)
29-03-2026
yahoo.com
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
23-03-2026
yahoo.com
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
21-03-2026
fool.com
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
25-02-2026
yahoo.com
The Bull Case For NewAmsterdam Pharma (NAMS) Could Change Following 2025 Results And New Share Offering
23-02-2026
yahoo.com
What is the current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The current price of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is $22.21.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is $-0.9.
NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) since the previous trading day is -3.8944%.
What is the most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent average sentiment score for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)?
The most recent sentiment for NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ) is .
SEC-8K** Filing Available For NEWAMSTERDAM PHARMA CO NV-27 (NAMSW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.